COVID-19 vaccine trials

Bharat Biotech’s Covaxin gets approval for emergency use for children aged 2-18 years

Two doses of Covaxin are expected to be distributed to children with a gap of 28 days. The government has set an interval of 4-6 weeks for adults between the two shots.

AIIMS Delhi: second dose trial of Covaxin on 2-6 years old children to take place

AIIMS in New Delhi will commence the second dose trial of Bharat Biotech's COVID-19 vaccine, Covaxin, for children aged 2-6 years.

Over 60% Indians are still hesitant to take vaccine, reveals survey

WHO removes ‘remdesivir’ from prequalification list for treatment of COVID-19

COVID-19 Vaccine: First batch of Russian candidate Sputnik-V to reach Kanpur for Phase 2 & 3 trials

. College principal R B Kamal confirmed that the human clinical trials of the vaccine begin next week.

Oxford University COVID-19 Vaccine trials resume in the UK, India and Japan, but on hold in the US

AstraZeneca and Oxford University's experimental COVID-19 vaccine clinical trials have resumed in Japan. The trials were put on a hold due to the illness of a British volunteer. On September 6, a study participant felt ill with what was believed to be a rare spinal inflammatory disorder called transverse myelitis.

Chinese COVID-19 Vaccines end in trail phase and could be released by November

Chinese claim COVID-19 Vaccines to be released as early as November given the close end of phase trails.

Report: Serum Institute order to suspend recruitment for COVID-19 vaccine trials

Brazil’s Bahia buys 50 million doses of Russian COVID-19 vaccine to conduct phase III trial

Brazilian state Bahia's Governor Rui Costa has said that an agreement has been signed to conduct Phase III clinical trials of the Russian COVID-19 vaccine 'Sputnik V.'

Serum Institute: COVID-19 vaccine trials have not faced any issues in India